IndraLab

Statements



reach
"EtBr treatment dose-dependently inhibited caspase-1 activation IL-1beta cleavage, and the secretion of IL-1beta and IL-18 in response to LPS and ATP treatment, but did not decrease amounts of pro IL-1beta (XREF_FIG)."

reach
"Although not affecting TNF production, EtBr treatment, which reduced mtDNA by approximately 90%, attenuated excessive IL-1beta release by p62 deficient macrophages stimulated with inflammasome activators and inhibited caspase-1 activation (XREF_FIG)."

reach
"Although not affecting TNF production, EtBr treatment, which reduced mtDNA by ~ 90%, attenuated excessive IL-1beta release by p62 deficient macrophages stimulated with inflammasome activators and inhi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"